Treatment library
Loading treatment roster
Preparing current medications, procedures, devices, and historical context.
Treatment library
Preparing current medications, procedures, devices, and historical context.
The historical combination of fenfluramine and phentermine that became a cautionary landmark in weight-loss drug history after valvular-heart-disease concerns led to withdrawal of the fenfluramine component.
Fen-Phen was not a single modern branded obesity product. The fenfluramine component was withdrawn after safety concerns.
Appetite suppression through older serotonergic and stimulant pathways
Not applicable as a current treatment pathway.
Appetite suppression through older serotonergic and stimulant pathways
The historical combination of fenfluramine and phentermine that became a cautionary landmark in weight-loss drug history after valvular-heart-disease concerns led to withdrawal of the fenfluramine component.
legacy
historical
1990s combination use
1997
Fen-Phen, Pondimin / Redux plus phentermine
fenfluramine / phentermine combination
Historical combination use; fenfluramine products were withdrawn
No. Historical only.
fenfluramine, phentermine
Historical treatment; not a current routine U.S. therapy.
Not applicable as a current treatment pathway.
Relevant as history, not as a current recommendation or realistic modern option.
Fen-Phen still shows up in public memory because it shaped how many people think about the risks of weight-loss drugs.
Its central relevance is as a warning case in obesity-drug history, especially around cardiac-valve and pulmonary-hypertension safety.
valvular heart disease risk, pulmonary hypertension risk, stimulant side effects, insomnia, dry mouth
Appetite suppression through older serotonergic and stimulant pathways
Historical combination prescribing rather than a current approved branded package.
Oral historical combination use.
Historical combination therapy
Oral historical combination use.
Its central relevance is as a warning case in obesity-drug history, especially around cardiac-valve and pulmonary-hypertension safety.
These are the official or reference sources used to anchor this treatment profile.
Treatment availability, dosing, cash pricing, and insurance coverage change often. Verify current details with your clinician, pharmacist, surgeon, device program, and insurer before starting, switching, or paying for treatment.